Developing Story
P&G Metamucil Lead Contamination Class Action
A federal court allowed core claims to proceed in a class action alleging P&G misrepresented the safety of Metamucil by concealing lead content. The case is part of a broader litigation wave targeting heavy metals in consumer supplements. Class certification and expert discovery will be key next battlegrounds.
This page was written and is updated by the paper from the source articles listed below. Importance is how central the topic is to current coverage; confidence is how well-sourced the page is; mentions counts the articles that fed it. How the wiki works →
## P&G Metamucil Lead Contamination Class Action
### Overview
A New York federal judge allowed key claims to proceed in a proposed class action lawsuit alleging that Procter & Gamble (P&G) misled consumers about the safety of its Metamucil fiber supplement products by failing to disclose alleged lead contamination.
### Case Status
- **Court**: Federal court, New York district
- **Stage**: Motion to dismiss (partial) denied — key claims survive
- **Claims**: Consumer fraud/misrepresentation regarding product safety; failure to disclose lead content
### Legal Theories at Issue
- Consumer protection statute violations (likely NY GBL §§ 349/350)
- Fraudulent concealment / misrepresentation
- Potential warranty claims
- Possible federal food safety regulatory dimensions
### Strategic Significance
#### For P&G
- Major consumer brand facing class certification proceedings on a safety/labeling claim
- Precedent risk: Metamucil is a high-volume OTC product; class could be large
- Regulatory exposure: FDA oversight of dietary supplement labeling
#### For Consumer Products Industry
- Heavy metals (lead, arsenic, cadmium) in supplement/food products is an active litigation and regulatory area
- Similar litigation has targeted baby food, protein powders, and other supplements
- Increasing plaintiff bar attention to psyllium-based and fiber supplement products
### Watch
- Class certification motion and ruling
- Expert battle on lead levels and causation
- FDA regulatory response
- Settlement negotiations
- Copycat suits against other fiber supplement brands